Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), brin...
EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The...
"Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens...
Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a struc...
Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing s...
The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...
What are Caidya’s major highlights for 2026 that will strengthen its presence in the global CRO market? And what a...
How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has annou...
Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...
